Mr. Speaker, I rise today in strong support of House Concurrent Resolution 473, a resolution recognizing September as the seventh annual Gynecologic Cancer Awareness Month. I and 74 of my colleagues…
Mr. Speaker, I rise today in strong support of House Concurrent Resolution 473, a resolution recognizing September as the seventh annual Gynecologic Cancer Awareness Month. I and 74 of my colleagues have co-sponsored this resolution. We firmly believe that raising public awareness, detecting gynecological cancers early, and educating women to the risk of reproductive tract cancers are powerful methods with which to combat this disease.
The Gynecological Cancer Foundation (GCF) seeks to promote these important goals by leading the Gynecological Cancer Awareness Month events and through the Foundation's work year-round. I commend the GCF for it efforts and accomplishments to date. I congratulate the GCF on the occasion of its 15th anniversary.
The Centers for Disease Control and Prevention (CDC) reports that 27,000 of 71,000 women diagnosed with gynecological cancers succumbed to their diseases during 2002. Uterine cancer is the most common among women today. Ovarian cancer is the most deadly. Cervical cancer, for instance, was a leading cause of death for American women. But medical advances and early detection efforts during the last 40 years have significantly increased a woman's chances of surviving it. But a revealing 2005 GCF poll showed that 45 percent of American women could not name a single symptom common to gynecological cancers. Clearly, more must be done here.
Through awareness, early detection, education and better treatment we can make more progress toward increasing survival rates for women at risk for or diagnosed with gynecological cancers. The passage of H. Con. Res. 437 will help improve the rate of early detection of these cancers. The passage of H. Con. Res. 437 will also help to save lives. Lastly, the adoption of H. Con. Res. 473 will help bolster gynecological cancers education and research. Taken together, these actions will help researchers and physicians discover better treatments and ultimately a cure for these debilitating cancers.
Raising awareness and early detection coupled with better education and treatment programs for women who suffer from gynecological cancers is of particular concern to my constituents. Guam does not have an oncologist. Most oncology services are thousands of miles away in Hawaii or on the mainland. Adequate care and information regarding gynecological cancers are similarly inaccessible for women from other isolated or rural communities across America. They are at particular risk. We must do more to help them.
I was among thousands of people who stood at the Reflecting Pool on the West front of the U.S. Capitol to honor cancer survivors and mourn the loss of those who succumbed to the disease last week. Attendees were invited to light a candle in memory of survivors and victims of cancer. Each candle represented a person's battle, a family's grief, and a community's struggle. I memorialized Guam's cancer survivors and victims in this way. This Ceremony of Hope was an emotional display of strength and optimism. But the sight of a sea of candles flickering before us was also a disturbing testimony to the loss and heartbreak associated with this dreadful disease.
I urge my colleagues to support H. Con. Res. 473. I would also like to take this opportunity to urge the House Energy and Commerce Committee to report H.R. 1245, the Cancer Education and Awareness Act. H.R. 1245 enjoys the support of 256 members of this body. The bill is colloquially known as Johanna's Law, named in memory of Johanna Silver Gordon, who lost her life to a battle with ovarian cancer which was not diagnosed until it had reached an advanced stage. Johanna's Law would make education and outreach on gynecological cancers an ongoing effort and a national priority. The House should have an opportunity to vote on this bill. Together, H. Con. Res. 473 and H.R. 1245 would do much to raise awareness and improve early detection of gynecological cancers while facilitating better education and treatment programs for women who suffer from gynecological cancers.